Showing posts with label health insurance. Show all posts
Showing posts with label health insurance. Show all posts

Sunday, July 12, 2015

We need telemedicine and this is why. - http://clapway.com/2015/07/12/ask-your-doctor-how-telemedicine-really-works-246/

Virtual consultations, or telemedicine is becoming increasingly popular. Could it save us money and change the doctor-patient relationship?


How telemedicine works


Telemedicine is the practice of patients and doctors having an appointment via the phone or computer – Skype, for instance. Many believe that it has the potential of expanding access to health care while providing cheaper services to patients.


Ask Your Doctor How Telemedicine Really Works - Clapway


Cost-effective and in line with technological change


If you struggle with transportation or access to healthcare, having the possibility of consulting your doctor virtually is a game-changer. Experts argue that virtual care also cuts emergency room costs for health providers while allowing doctors to see more patients. Furthermore, home care and monitoring of those in need of long-term assistance could be easily accomplished remotely.


Ask Your Doctor How Telemedicine Really Works - Clapway


Remote healthcare in emergency situations


Dr. Lawrence R. Wechsler, chairman of the Department of Neurology, University of Pittsburgh Schools of the Health Sciences, and vice president of telemedicine services, believes that in the treatment of stroke, for instance, “telemedicine can offer a huge advantage”. An expert doctor hundreds of miles away from a local hospital can treat patients within minutes.


Timely interventions can significantly reduce stroke-related disabilities.


In terms of economic savings, using telemedicine could cut insurance costs. Human resources consultancy Towers Watson estimates the savings at $6 billion a year for companies that buy coverage for employees.


Is telemedicine sustainable?


In order to make telemedicine a sustainable model, experts have urged U.S. states to recognise it as a reimbursable service.


“A lot of (our services) have been held back a little bit by the lack of reimbursement,” said Matt Levi, director of virtual health services at CHI Franciscan.


In CHI Franciscan, the service has been around for a few year.


According to the New York Times, if some health systems and insurers are rushing to offer video consultations for routine ailments, telemedicine is also facing “pushback from some more traditional corners of the medical world”.


More and more health providers, however, are stepping up to provide telemedicine services to a broader population – in urban and rural areas alike.


Ask Your Doctor How Telemedicine Really Works - Clapway


The technology is out there


As telemedicine service connects patients with health-care providers, the system also brings technology into peoples’ homes.


“We sent tablet technology into the homes of patients who are at end-of-life and they connected weekly with their physicians for their appointments,” said Thunder Bay Regional Health Sciences Centre manager of telemedicine and palliative care Trina Diner.


“The technology is out there,” she said. “It’s a lot less expensive than it used to be and a lot of people are a lot more comfortable with technology so all the conditions are right for us to move into that environment”.


Would you ever use telemedicine services?



 


For more technology-related news, check out Clapway Trends:



 



Ask Your Doctor How Telemedicine Really Works

Saturday, July 11, 2015

$1000 Hepatitis C Drug Is Replaced by More Expensive Alternative - http://clapway.com/2015/07/11/1000-hepatitis-c-drug-is-replaced-by-more-expensive-alternative678/

Most Americans suffering from hepatitis C must pay $1350 for each and every pill of the newly designed drug Harvoni, compared to last year when doctors’ favourite drug, Sovaldi, cost “only” $1000 a pill. Harvoni had already accounted for three quarters of the Hepatitis C prescriptions made in this year’s first three months. This more expensive alternative has been introduced by the same pharmaceutical company, Gilead Sciences. With hepatitis C being more deadly than HIV and claiming 3 million patients in the US, the similarities between the marketing strategies of Apple and that of some pharmaceutical companies seem rather dismaying: paying more for the latest drug may not be as justifiable as in the case of the latest iPhone.


More patients each year


The number of patients who report suffering from hepatitis C has risen over the years and in the last year only, the number of released prescriptions has doubled. According to doctor Douglas Dieterich at the Mount Sinai Hospital in New York City, this happened due to an increase in the willingness of people to be treated. While this seems to be due to the efficiency of newer drugs which have less adverse effects, the fact is that results are the same if not worse in terms of the curing rates. “When I started in 1989, I used to have a 3 percent cure rate. Now I have a 3 percent failure rate,” said doctor Dietrich. In this case, why should people buy more expensive drugs?


Low competition and high demand allow for high cost of pill


Harvoni seems to have obvious advantages compared to other hepatitis C drugs in terms of its low impact on the patient’s lifestyle. It only needs to be taken once a day and for a maximum of 12 weeks, without requiring the simultaneous administration of other drugs. By comparison, its cheaper competitor, Viekira Pak, should be taken four times daily. While the latter is reported to be equally effective, simplicity seems to be the main factor in choosing drug treatments. But choosing exorbitantly expensive drugs just for the sake of easy administration seems like a weak argument.


Solutions?


DRX surveys of private health plans indicate that the patients on Harvoni benefitted from a 13.7 discount between the months of April and June. Jim Yocum, the DRX executive vice president, worries that this will influence cancer drug companies in pushing for more expensive drugs on the market. In the meantime, Medicare is forbidden to have its say in the drug pricing strategies. Solutions seem scarce at this present moment, but Cara Miller, the spokeswoman for Gilead, has stated that the company is trying to widen the accessibility of its product to the public by working with private insurers.



 


Stay healthy and keep your immune system up, so that you don’t have to spend a grand on one pill. use the nutribullet system.




$1000 Hepatitis C Drug Is Replaced by More Expensive Alternative